• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C.

作者信息

Kanda T, Yokosuka O

机构信息

Department of Gastroenterology, Chiba University Hospital, Japan.

出版信息

JNMA J Nepal Med Assoc. 2011 Jan-Mar;51(181):41-8.

PMID:22335095
Abstract

Until HCV NS3/4A protease inhibitors become available at the end of 2011, the combination pegylated-interferon (PEG-IFN)-alfa and ribavirin (RBV) will remain the standard treatment for chronic hepatitis C patients. In some hepatitis C virus-infected patients, PEG-IFN plus RBV treatment against HCV should continue to be used because of side effects of new drugs such as anemia. Our Japanese experiences should provide new information for the treatment of chronic hepatitis C.

摘要

相似文献

1
Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C.
JNMA J Nepal Med Assoc. 2011 Jan-Mar;51(181):41-8.
2
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.甲硫米泊苷、聚乙二醇干扰素和利巴韦林用于1型慢性丙型肝炎中对聚乙二醇干扰素和利巴韦林无反应者的治疗。
Hepatology. 2009 Dec;50(6):1719-26. doi: 10.1002/hep.23204.
3
Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients.聚乙二醇干扰素联合利巴韦林治疗持续病毒学应答可使丙型肝炎病毒感染患者的肝硬度恢复正常。
Enferm Infecc Microbiol Clin. 2013 Aug-Sep;31(7):424-9. doi: 10.1016/j.eimc.2012.12.004. Epub 2013 Feb 28.
4
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.西美瑞韦联合聚乙二醇干扰素 α-2a 和利巴韦林治疗初治慢性丙型肝炎病毒 1 型感染患者（QUEST-1）：一项 3 期、随机、双盲、安慰剂对照试验。
Lancet. 2014 Aug 2;384(9941):403-13. doi: 10.1016/S0140-6736(14)60494-3. Epub 2014 Jun 4.
5
Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.西美瑞韦联合聚乙二醇干扰素 α-2a 或 -2b 加利巴韦林治疗初治慢性丙型肝炎病毒基因 1 型感染患者（QUEST-2）：一项随机、双盲、安慰剂对照的 3 期临床试验。
Lancet. 2014 Aug 2;384(9941):414-26. doi: 10.1016/S0140-6736(14)60538-9. Epub 2014 Jun 4.
6
Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin.用达诺普韦治疗14天以及用聚乙二醇化α-2a干扰素（40KD）加利巴韦林治疗48周后的持续病毒学应答。
Antivir Ther. 2012;17(5):927-32. doi: 10.3851/IMP2126. Epub 2012 May 18.
7
[Combined telaprevir plus ribavirin and pegylated interferon therapy for patients with chronic hepatitis C].
Nihon Rinsho. 2015 Feb;73(2):259-65.
8
Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination therapy for chronic hepatitis C.促红细胞生成素α治疗慢性丙型肝炎干扰素联合利巴韦林治疗期间的急性贫血
J Viral Hepat. 2004 May;11(3):191-7. doi: 10.1111/j.1365-2893.2004.00506.x.
9
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.儿童慢性丙型肝炎患者接受聚乙二醇干扰素 alfa-2b 联合利巴韦林治疗的高持续病毒学应答率。
J Hepatol. 2010 Apr;52(4):501-7. doi: 10.1016/j.jhep.2010.01.016. Epub 2010 Feb 4.
10
[Triple combination treatment of chronic hepatitis C].
Vnitr Lek. 2012 Jul-Aug;58(7-8):588-90.

引用本文的文献

1
polymorphism as a predictor of chronic hepatitis C treatment efficiency in Ukrainian patients.多态性作为乌克兰患者慢性丙型肝炎治疗效果的预测指标
Cytol Genet. 2016;50(5):330-333. doi: 10.3103/S0095452716050066. Epub 2016 Oct 11.